In this study, the possible association between pancreatitis and treatment with methylglucamine antimoniate (MA) in dogs with leishmaniasis was evaluated. Of the 20 dogs included, three dogs showed clinical signs of pancreatitis. Abdominal ultrasound abnormalities suggestive of pancreatitis were observed in two dogs, and increased cPLI was observed in four cases. The statistical results showed a low probability of development of pancreatitis in patients treated with MA. However, considering the possible recurrence of pancreatitis in four cases in our study, we suggest that dogs treated with MA should be evaluated for pancreatitis, especially when compatible clinical signs are present.
|Titolo:||The association between N-methylglucamine antimoniate and pancreatitis in dogs with leishmaniasis|
|Autori interni:||BOARI, Andrea|
DI SILVERIO, FRANCESCA
|Data di pubblicazione:||2012|
|Appare nelle tipologie:||2.1 Contributo in volume (Capitolo o Saggio)|